Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

Simple item page
dc.contributor.authorPhillips, Richard Odame
dc.date.accessioned2020-01-08T14:42:42Z
dc.date.accessioned2023-04-19T01:37:21Z
dc.date.available2020-01-08T14:42:42Z
dc.date.available2023-04-19T01:37:21Z
dc.date.issued2016-12-15
dc.descriptionAn article published by Lancet Gastroenterol Hepatol 2017; 2: 161–76 and available at http://dx.doi.org/10.1016/ S2468-1253(16)30181-9en_US
dc.description.abstractThe 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the recent launch of direct acting antiviral therapies. Reliable disease burden estimates are required for national strategies. This analysis estimates the global prevalence of viraemic HCV at the end of 2015, an update of—and expansion on—the 2014 analysis, which reported 80 million (95% CI 64–103) viraemic infections in 2013.en_US
dc.description.sponsorshipKNUSTen_US
dc.identifier.citationLancet Gastroenterol Hepatol 2017; 2: 161–76en_US
dc.identifier.urihttps://ir.knust.edu.gh/handle/123456789/11853
dc.language.isoenen_US
dc.publisherLancet Gastroenterol Hepatolen_US
dc.titleGlobal prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling studyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Global prevalence and genotype distribution of hepatitis C.pdf
Size:
1.07 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
license.txt
Size:
1.73 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Articles